Although the biological potential of gastric epithelial dysplasia (GED) as a precursor of gastric cancer has never been in doubt, the classification of these lesions has been controversial and fraught with marked variations in approach to diagnosis across the world. The complexity of cyto-architectural features has been considered to be of paramount importance for the diagnosis of carcinoma in Japan, while breach of the basement membrane and invasion into the lamina propria has been considered the sine qua non of malignancy and hence a pre-requisite for the diagnosis of cancer in the West. In Korea, although the incidence of gastric cancer is similar to Japan, the diagnostic approach to GED or cancer seems to lie midway between Western and Japanese criteria. In this review, we will discuss the difference in the diagnosis of GED and cancer between two pathologists working in the comprehensive cancer center located in Japan and Korea, one of the most prevalent areas in the world for gastric cancer.
Introduction
The advent of the flexible endoscope and its world-wide use in clinical practice has had a major impact on the management of gastric cancer.(1) Histopathologic diagnosis remains the foundation of clinical decision making in the treatment of gastric neoplasia.
However, based on subjective morphologic criteria, clinicians and pathologists continue to have concerns about the ability of pathologists to achieve consistent and accurate diagnoses using published criteria. (2) In 2000, a group of gastrointestinal pathologists convened in Vienna, Austria, for the purpose of developing a new system for the classification of dysplasia that would help to minimize the widely recognized discrepancies in morphological interpretation of gastric epithelial dysplasia (GED) and to reach consensus on the nomenclature.(3) However, modification of the nomenclature has not resolved the high level of intra-and interobserver variability with regard to the pathological classification of neoplasia and its mimickers. These interobserver variations are not a problem confined to Western and Japanese regions, and poor interobserver agreement in the distinction between high-grade dysplasia and adenocarcinoma in the pretreatment biopsies of Brrett's esophagus has been reported among pathologists practicing in the same institute located in United States, where Barrett's esophagus is one of the most common medical conditions. (4) In Japan, gastric carcinoma is diagnosed on nuclear and structural criteria, even when invasion is absent according to the Western viewpoint. (5) This may also contribute to the relatively high incidence and good prognosis of gastric carcinoma in Japan compared to Western countries. In Korea, the terminology, definitions, and diagnostic criteria for GED are very heterogeneous.(6) As one of the pathologists working in a large volume hospital and handling a large number of gastric biopsy specimens, our experiences in the pathologic diagnosis of GED and carcinoma might help identify the differences between Korea and Japan.
Materials and Methods
In July 2008, to observe interobserver variation between two pathologists working in two different countries, KMK visited RK in Japan with her collection of gastric biopsy specimens with follow up information and that were associated with diagnostic difficulty.
Without any knowledge of follow up or diagnosis by KMK, RK diagnosed the H&E slides of KMK's gastric biopsy specimens.
Results
The overall differences in the diagnosis of gastric biopsies are depicted in Table 1 .
Regenerative atypia
In the diagnosis of regenerative atypia, although we reached agreement in most cases ( Fig. 1) , we disagreed on two cases. One case ( Fig. 2 ) diagnosed as regenerative atypia by KMK was diagnosed as suspicious carcinoma by RK and the other one diagnosed as favor reactive atypia was diagnosed as atypical glands with highgrade dysplasia by KMK (Fig. 3) .
In cases that are difficult to diagnose, whether they are neoplasia, dysplasia or regenerative atypia, the Japanese guideline recommends making a temporary diagnosis of 'Group 2, indefinite LGD = low-grade dysplasia; HGD = high-grade dysplasia; NIAdc = non-invasive adenocarcinoma by RK. *Suspicious, but not conclusive of adenocarcinoma.
Fig. 1. Gastric biopsies diagnosed as erosion by both RK and KMK.
Although the pit shows neutrophilic abscesses, there was no epithelial cell necrosis, suggesting erosion rather than neoplasia.
Fig. 2. Gastric biopsies diagnosed as suspected adenocarcinoma by RK.
This patient was diagnosed with esophageal squamous cell carcinoma and had received chemo-radiation therapy for 3 months. KMK diagnosed this case as regenerative atypia.
for neoplasia'. This corresponds to 'Category 2' of the Vienna classification (Table 2 ). 
GED (adenoma)
In the diagnosis of GED, we used "adenoma" in daily practice. 
Adenocarcinoma
In cases diagnosed as invasive adenocarcinoma, distinct struc- grade dysplasia (Fig. 6 ). This trend was more evident in histology when the tumor was gastric foveolar phenotype (Fig. 7) . In Japan, the differential diagnosis between adenoma and adenocarcinoma is made on the basis of cellular and structural atypia. Even for small biopsy specimens, Japanese pathologists diagnose carcinoma if the tumor shows the same cellular and/or structural atypia as those of invasive carcinomas.
Adenocarcinoma in an adenoma
In the diagnosis of adenocarcinoma arising from an adenoma, RK used "adenocarcinoma associated with adenoma" when there was good circumscription of the carcinoma from the surrounding or adjacent adenoma, which shows clearly different histology from the carcinoma ( 
Conclusions
Although interobserver variation was present, it was not extreme and didn't affect treatment plans. However, diagnosing carcinoma on the basis of cellular and structural atypia, such as is done in Japan, may lead to a higher prevalence of gastric carcinoma and relatively good therapeutic results. Further international studies would help pathologists improve poor interobserver agreement in the distinction between high-grade dysplasia and adenocarcinoma.
